生命科学2024,Vol.36Issue(6) :818-830.DOI:10.13376/j.cbls/2024084

O-GlcNAcylation对抗癌治疗效果的影响及其机制

Implications and mechanisms of O-GlcNAcylation on anti-cancer therapy efficacy

马斌媛 高宏伟 尤崇革 潘云燕
生命科学2024,Vol.36Issue(6) :818-830.DOI:10.13376/j.cbls/2024084

O-GlcNAcylation对抗癌治疗效果的影响及其机制

Implications and mechanisms of O-GlcNAcylation on anti-cancer therapy efficacy

马斌媛 1高宏伟 1尤崇革 1潘云燕1
扫码查看

作者信息

  • 1. 兰州大学第二医院检验医学中心,兰州 730000
  • 折叠

摘要

O-连接-N-乙酰氨基葡萄糖化(O-linked β-N-acetylglucosamine,O-GlcNAcylation)是蛋白质翻译后修饰(protein translation modifications,PTMs)的一种,调节各种基本的细胞生物学过程,包括基因转录、信号转导、应激反应和细胞代谢等.目前,O-GlcNAcylation对肿瘤进展的影响己被认可,但其在抗癌疗效中的作用尚未被阐明.因此,本文旨在综述失调的O-GlcNAcylation影响抗癌治疗效果的最新证据,分析O-GlcNAcylation水平失调影响抗癌疗效的几种可能的机制,讨论靶向O-GlcNAcylation作为癌症治疗增敏剂的可能性,为提高抗癌治疗效果提供理论参考.

Abstract

O-linked β-N-acetylglucosamine(O-GlcNAcylation)is one of the protein translation modifications(PTMs)that regulate a variety of fundamental cellular biological processes,including gene transcription,signal transduction,stress response and cell metabolism.The role of dysregulated O-GlcNAcylation in tumorigenesis has been recognized,but its role in the anti-cancer therapy efficacy has not been elucidated.Therefore,this article reviews the latest evidence that dysregulated O-GlcNAcylation affects anti-cancer therapy efficacy,analyzes several possible mechanisms by which dysregulated O-GlcNAcylation levels affect anti-cancer therapy efficacy,and discusses the possibility of targeting O-GlcNAcylation as a cancer therapeutic sensitizer,aiming to provide theoretical references to improve the efficacy of anti-cancer therapy.

关键词

O-GlcNAcylation/O-GlcNAc转移酶/抗癌治疗/耐药/化疗耐药/翻译后修饰

Key words

O-GlcNAcylation/O-GlcNAc transferase/anti-cancer therapy/drug resistance/chemoresistance/post-translational modification

引用本文复制引用

基金项目

国家自然科学基金面上项目(81972498)

甘肃省自然科学基金项目(23JRRA1634)

出版年

2024
生命科学
国家自然科学基金委员会生命科学部 中国科学院生命科学与生物技术局 中国科学院生命科学和医学学部 中国科学院上海生命科学研究院

生命科学

CSTPCDCSCD
影响因子:0.542
ISSN:1004-0374
参考文献量114
段落导航相关论文